Aims. Clear cell
Aims. Current literature suggests that survival outcomes and local recurrence rates of primary soft-tissue
The Australia and New Zealand
The NZ Standards of Service Provision for
The April 2023 Oncology Roundup. 360. looks at: Complete tumour necrosis after neoadjuvant chemotherapy defines good responders in patients with Ewing’s
Paediatric bone
Aims. Socioeconomic and racial disparities have been recognized as impacting the care of patients with cancer, however there are a lack of data examining the impact of these disparities on patients with bone
Wide resection, with or without adjuvant therapy, is the mainstay of treatment for soft tissue
Aims. Cell-free DNA (cfDNA) and circulating tumour DNA (ctDNA) are used for prognostication and monitoring in patients with carcinomas, but their utility is unclear in
Aims. Surgical limb sparing for knee-bearing paediatric bone
In 2004 the Scottish
Aims. Survival rates and local control after resection of a
Aims. Iliosacral
Aims. Delays to diagnosis and management of soft tissue
Aims. The aim of this study was to evaluate the surgical management and outcome of patients with an acral soft-tissue
Aims. The aim of this study was to identify factors associated with five-year cancer-related mortality in patients with limb and trunk soft-tissue
The Specialist
Prediction tools are instruments which are commonly used to estimate the prognosis in oncology and facilitate clinical decision-making in a more personalized manner. Their popularity is shown by the increasing numbers of prediction tools, which have been described in the medical literature. Many of these tools have been shown to be useful in the field of soft-tissue
Aims. The aims of the study were to analyze differences in surgical and oncological outcomes, as well as quality of life (QoL) and function in patients with ankle
Aim. Local treatment of Ewing